General contact

Main switchboard

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST


Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999


Investor Relations

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

American Depository Receipts (ADR)

Since May 11, 2000, Novartis shares also have been available in the form of American Depositary Receipts (ADRs) traded on the New York Stock Exchange. Novartis ADRs are listed on the New York Stock Exchange under the trading symbol "NVS" at prices quoted in US dollars.

Novartis no longer provides a direct share purchase plan. For information regarding purchase of Novartis ADRs through JPMorgan Chase's Global Invest Direct Plan, please call toll-free: 1-(800) 428-4237.

Stock chart
Q3 Results 2013

On Thursday, April 24, Novartis will announce its results for the first quarter of 2014